Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 10 (Search time: 0.003 seconds).
previous
1
next
Item hits:
Preview
Issue Date
Title
Author(s)
2004
Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia
Mollee, P.
;
Arthur, C.
;
Hughes, T.
;
Januszewicz, H.
;
Grigg, A.
;
Bradstock, K.
;
Wolf, M.
;
Gibson, J.
;
Schwarer, A.
;
Spencer, A.
;
Browett, P.
;
Hawkins, T.
;
Seldon, M.
;
Herrmann, R.
;
Watson, A.
;
Seymour, J.
;
Martin, N.
;
Shina, S.
;
Low, C.
;
Wright, S.
;
et al.
2006
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Druker, B.
;
Guilhot, F.
;
O'Brien, S.
;
Gathmann, I.
;
Kantarjian, H.
;
Gattermann, N.
;
Deininger, M.
;
Silver, R.
;
Goldman, J.
;
Stone, R.
;
Cervantes, F.
;
Hochhaus, A.
;
Powell, B.
;
Gabrilove, J.
;
Rousselot, P.
;
Reiffers, J.
;
Cornelissen, J.
;
Hughes, T.
;
Agis, H.
;
Fischer, T.
;
et al.
2016
Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients
Deininger, M.
;
Hodgson, J.
;
Shah, N.
;
Cortes, J.
;
Kim, D.
;
Nicolini, F.
;
Talpaz, M.
;
Baccarani, M.
;
Müller, M.
;
Li, J.
;
Parker, W.
;
Lustgarten, S.
;
Clackson, T.
;
Haluska, F.
;
Guilhot, F.
;
Kantarjian, H.
;
Soverini, S.
;
Hochhaus, A.
;
Hughes, T.
;
Rivera, V.
;
et al.
2008
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
le Coutre, P.
;
Ottmann, O.
;
Giles, F.
;
Kim, D.
;
Cortes, J.
;
Gattermann, N.
;
Apperley, J.
;
Larson, R.
;
Abruzzese, E.
;
O'Brien, S.
;
Kuliczkowski, K.
;
Hochhaus, A.
;
Mahon, F.
;
Saglio, G.
;
Gobbi, M.
;
Kwong, Y.
;
Baccarani, M.
;
Hughes, T.
;
Martinelli, G.
;
Radich, J.
;
et al.
2013
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M.
;
Deininger, M.
;
Rosti, G.
;
Hochhaus, A.
;
Soverini, S.
;
Apperley, J.
;
Cervantes, F.
;
Clark, R.
;
Cortes, J.
;
Guilhot, F.
;
Hansen-Hjorth, H.
;
Hughes, T.
;
Kantarjian, H.
;
Kim, D.
;
Larson, R.
;
Lipton, J.
;
Mahon, F.
;
Martinelli, G.
;
Mayer, J.
;
Muller, M.
;
et al.
2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL
Tojo, A.
;
Usuki, K.
;
Urabe, A.
;
Maeda, Y.
;
Kobayashi, Y.
;
Jinnai, I.
;
Ohyashiki, K.
;
Nishimura, M.
;
Kawaguchi, T.
;
Tanaka, H.
;
Miyamura, K.
;
Miyazaki, Y.
;
Hughes, T.
;
Branford, S.
;
Okamoto, S.
;
Ishikawa, J.
;
Okada, M.
;
Usui, N.
;
Tanii, H.
;
Amagasaki, T.
;
et al.
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
O'Brien, S.
;
Guilhot, F.
;
Larson, R.
;
Gathmann, I.
;
Baccarani, M.
;
Cervantes, F.
;
Cornelissen, J.
;
Fischer, T.
;
Hochhaus, A.
;
Hughes, T.
;
Lechner, K.
;
Nielsen, J.
;
Rousselot, P.
;
Reiffers, J.
;
Saglio, G.
;
Shepherd, J.
;
Simonsson, B.
;
Gratwohl, A.
;
Goldman, J.
;
Kantarjian, H.
;
et al.
2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Nieborowska-Skorska, M.
;
Kopinski, P.
;
Ray, R.
;
Hoser, G.
;
Ngaba, D.
;
Flis, S.
;
Cramer, K.
;
Reddy, M.
;
Koptyra, M.
;
Penserga, T.
;
Glodkowska-Mrowka, E.
;
Bolton, E.
;
Holyoake, T.
;
Eaves, C.
;
Cerny-Reiterer, S.
;
Valent, P.
;
Hochhaus, A.
;
Hughes, T.
;
Van der Kuip, H.
;
Sattler, M.
;
et al.
2011
SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemia
Esposito, N.
;
Colavita, I.
;
Quintarelli, C.
;
Sica, A.
;
Peluso, A.
;
Luciano, L.
;
Picardi, M.
;
Vecchio, L.
;
Buonomo, T.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Russo, D.
;
Branford, S.
;
Saglio, G.
;
Vaz de Melo, J.
;
Martinelli, R.
;
Ruoppolo, M.
;
Kalebic, T.
;
Martinelli, G.
;
et al.
2018
Role of the β common (βc) family of cytokines in health and disease
Hercus, T.
;
Kan, W.
;
Broughton, S.
;
Tvorogov, D.
;
Ramshaw, H.
;
Sandow, J.
;
Nero, T.
;
Dhagat, U.
;
Thompson, E.
;
Tung Shing, K.
;
McKenzie, D.
;
Wilson, N.
;
Owczarek, C.
;
Vairo, G.
;
Nash, A.
;
Tergaonkar, V.
;
Hughes, T.
;
Ekert, P.
;
Samuel, M.
;
Bonder, C.
;
et al.
Discover
Author
6
Hochhaus, A.
4
Baccarani, M.
4
Guilhot, F.
4
Kantarjian, H.
3
Cervantes, F.
3
Cortes, J.
3
Deininger, M.
3
Kim, D.
3
Larson, R.
3
Martinelli, G.
.
next >
Subject
7
Humans
5
Antineoplastic Agents
5
Benzamides
5
Imatinib Mesylate
5
Piperazines
5
Pyrimidines
4
Female
4
Fusion Proteins, bcr-abl
4
Male
3
Adult
.
next >
Date issued
5
2010 - 2018
5
2003 - 2009